Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs iShares Global Clean Energy ETF (ICLN) Price & Performance

Gilead Sciences, Inc.Trade
iShares Global Clean Energy ETFTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs iShares Global Clean Energy ETF — how do they compare? Gilead Sciences, Inc. trades at $135.34 (market cap $168.35B), while iShares Global Clean Energy ETF trades at $18.5. The key difference: Gilead Sciences, Inc. pays a 2.42% dividend while iShares Global Clean Energy ETF pays none. Which is the better fit depends on your goals.

GILDICLN
Market Cap
$168.35B
Sector
Health
52-Week High
$155.80$23.75
52-Week Low
$110.56$13.66
Enterprise Value
$191.42B
Dividend Yield
2.42%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About iShares Global Clean Energy ETF

The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Read more on ICLN